BTG Share News (BTG)

BTG expects higher annual revenue, hikes guidance for 2015

Healthcare group BTG said it expected annual revenue to be "slightly" higher than indicated earlier this year. The FTSE 250 group said expected revenue for the year ended 31 March would be above the previous guidance it provided of £345m to £360m, including revenue from the PneumRx acquisition it co

LONDON MORNING BRIEFING: M&S UK Performance Beats Hopes

MARKET COMMENT: FTSE 100 Seen Lower; Oil Prices Came Down Overnight

BTG Says Revenue To Beat Hopes, Continue Growing Strongly

BTG starts selling its products to European hospitals

Healthcare company BTG said it started selling its drug-eluting bead and embolisation products to customers in 11 European countries. The products, DC Bead and Bead Block, will be sold directly to hospitals in Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Portugal, Switzerland, Spa

LONDON MORNING BRIEFING: M&A In Focus In Mid-Cap Sector

BTG Starts Direct Sales Of DC Bead, Bead Block Products In Europe

BTG Eyes US Investors With Launch Of ADR Programme (ALLISS)

BTG boosts full-year guidance thanks to PneumRx acquisition

After currencies moved in its favour and the completion of a recent acquisition, healthcare group BTG has raised its guidance for full-year revenue. Full-year revenue is now expected to range between £345m and £360m, around 4% higher than the previous guidance of £330m to £345m. The FTSE 250 group

BTG Increases Revenue Guidance On Acquisition, Currency Impact Reverse

UK WINNERS & LOSERS: Hargreaves Lansdown Hit After Profit Drop

UK BROKER RATINGS: Numis Cuts Hargreaves Lansdown To Add From Buy

BTG confirms completion of US PneumRx pulmonology business

Specialist healthcare company BTG said it had completed its acquisition of US interventional pulmonology business PneumRx, which will cost the FTSE 250 group up to £315m. The acquisition had been conditional on the expiration or early termination of a waiting period under the Hart-Scott-Rodino Act i

Tuesday broker round-up

Aberdeen: Cantor Fitzgerald initiates with a target price of 520p and a 'buy' recommendation. Aggreko: Jefferies reduces target price from 1810p to 1350p, downgrading to 'underperform'. Ashcourt Rowan: Cantor Fitzgerald initiates with a target price of 270p and a 'buy' recommendation. Ashmore: Can

Friday tips round-up: DS Smith, BTG

Specialist packaging manufacturer DS Smith has proven adept at growing with its clients, acquiring rivals and moving into new niches and geographies. That has seen the company transformed from a maker of paper into a manufacturer of higher-margin specialist packaging. A case in point is the recent a